ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,456.34
      -1.79%
      US Tech 100
      18,667.60
      -2.90%
      Dow Jones
      40,028.16
      -0.82%
      Brent Oil
      81.125
      0.43%
      Bitcoin
      66,385.74
      0.70%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Jpmorgan China Growth & Income Plc (JCGI) Quote

      Jpmorgan China Growth & Income Plc

      Jpmorgan China Growth & Income Plc (JCGI)

      LSE
      201.50
      -3.00
      (-1.47%)
      Closed July 24 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      201.50
      Bid
      202.00
      Ask
      204.00
      Volume
      186,817
      201.50 Day's Range 204.00
      189.00 52 Week Range 291.00
      Market Cap
      167.653M
      Previous Close
      204.50
      Open
      204.00
      Last Trade
      25000
      @
      200.82
      (O)
      Last Trade Time
      Financial Volume
      378,363p
      VWAP
      202.5315
      Average Volume (3m)
      225,266
      Shares Outstanding
      83,202,465
      Dividend Yield
      5.48%
      PE Ratio
      -3.91
      Earnings Per Share (EPS)
      -0.52
      Revenue
      -36.89M
      Net Profit
      -43.13M

      About Jpmorgan China Growth & Income Plc

      Sector
      Trust,ex Ed,religious,charty
      Industry
      Investment Trusts Div'd
      Website
      www.jpmchinagrowthandincome.co.uk
      Headquarters
      London, Gbr
      Founded
      1993
      Jpmorgan China Growth & Income Plc is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker JCGI. The last closing price for Jpmorgan China Growth & ... was 204.50p. Over the last year, Jpmorgan China Growth & ... shares have traded in a share price range of 189.00p to 291.00p.

      Jpmorgan China Growth & ... currently has 83,202,465 shares outstanding. The market capitalization of Jpmorgan China Growth & ... is £170.15 million. Jpmorgan China Growth & ... has a price to earnings ratio (PE ratio) of -3.91.

      JCGI Latest News

      More News

      JPMorgan China Growth & Income PLC Net Asset Value(s)

      JPMorgan China Growth & Income PLC 24 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      7 hours ago
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Net Asset Value(s)

      JPMorgan China Growth & Income PLC 23 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      July 23 2024
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Holding(s) in Company

      JPMorgan China Growth & Income PLC 22 July 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0003435012 Issuer Name JPMORGAN CHINA GROWTH & INCOME...

      July 22 2024
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Gearing Announcement

      JPMorgan China Growth & Income PLC 22 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      July 22 2024
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Net Asset Value(s)

      JPMorgan China Growth & Income PLC 22 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      July 22 2024
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Net Asset Value(s)

      JPMorgan China Growth & Income PLC 19 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      July 19 2024
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Net Asset Value(s)

      JPMorgan China Growth & Income PLC 18 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      July 18 2024
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Net Asset Value(s)

      JPMorgan China Growth & Income PLC 17 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      July 17 2024
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Net Asset Value(s)

      JPMorgan China Growth & Income PLC 16 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      July 16 2024
      RNS Regulatory News

      JPMorgan China Growth & Income PLC Gearing Announcement

      JPMorgan China Growth & Income PLC 15 July 2024   JPMORGAN CHINA GROWTH & INCOME PLC (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

      July 15 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-11-5.17647058824212.5214.5201.5141015207.82394735DE
      4-19-8.61678004535220.5225201.5162302215.55181969DE
      12-24-10.6430155211225.5262201.5225266231.46214394DE
      26-3.5-1.70731707317205262190.8218366219.39970717DE
      52-53.5-20.9803921569255291189206083226.71000106DE
      156-401.5-66.583747927603603189215938350.03022757DE
      260-90.5-30.9931506849292872189242406458.03413433DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NUZENuZee Inc
      $ 3.3401
      (224.28%)
      		94.99M
      DRMADermata Therapeutics Inc
      $ 2.7099
      (108.45%)
      		56.7M
      PIRSPieris Pharmaceuticals Inc
      $ 14.20
      (77.94%)
      		5.18M
      QXOQXO Inc
      $ 130.50
      (64.56%)
      		135.9k
      BBLGBone Biologics Corporation
      $ 2.0302
      (62.42%)
      		37.19M
      NXTTNext Technology Holding Inc
      $ 3.0987
      (-46.76%)
      		740.37k
      NUWENewellis Inc
      $ 2.48
      (-40.24%)
      		867.16k
      CONNConns Inc
      $ 0.33
      (-34.91%)
      		3.13M
      CJETChijet Motor Company Inc
      $ 3.4096
      (-32.88%)
      		321.11k
      VWEVintage Wine Estates Inc
      $ 0.0754
      (-32.62%)
      		21.26M
      SLNASelina Hospitality PLC
      $ 0.0358
      (37.69%)
      		934.59M
      SGMOSangamo Therapeutics Inc
      $ 0.64105
      (59.74%)
      		207.22M
      NVDANVIDIA Corporation
      $ 116.0601
      (-5.33%)
      		144.62M
      SQQQProShares UltraPro Short QQQ
      $ 8.935
      (9.23%)
      		114.36M
      TSLATesla Inc
      $ 220.35
      (-10.56%)
      		111.89M

      Discussion

      View Full Feed
      pos_stock_hoarder pos_stock_hoarder 3 minutes ago
      https://resources.arcamax.com/newspics/298/29899/2989945.gif
      Handlamera Handlamera 3 minutes ago
      Ok, investors and employees around the world suffer.
      How do you think you can help them by writing nonsense and trying to harm Laxmi and the company? Please explain.
      ITUP
      SCAMBUSTERKING SCAMBUSTERKING 3 minutes ago
      Finally an update on the shame social media case, they have asked for an extension of time because they have to domesticate the subpeona's, which I (a non-lawyer) knew the whole time. Therefore they asked to extend till Dec LOL!!! This is what you get when you use a discount dollar tree lawyer.
      SONG
      quigley24 quigley24 3 minutes ago
      2 things they need to address and sad they have not.......why sales were down by appr 4 million in June and why LYNX has not closed.....
      IQST
      gail gail 3 minutes ago
      lol
      BBLG
      Gmenfan Gmenfan 3 minutes ago
      https://i0.wp.com/politicallyincorrecthumor.com/wp-content/uploads/2024/07/changing-clowns-wont-change-circus-actors-scripted-puppeteers.jpg?resize=583%2C421&ssl=1
      shoondale shoondale 3 minutes ago
      Pipedream sold to suckers...20_years of return to drawing board.
      https://i.gifer.com/4dbC.gif
      MGON
      brazen22 brazen22 3 minutes ago
      hopefully, you're not the sap in the family tree
      NWBO
      Gmenfan Gmenfan 3 minutes ago
      https://i0.wp.com/politicallyincorrecthumor.com/wp-content/uploads/2024/07/quote-kid-rock-trump-77-years-without-felony-brainwashed.jpg?resize=530%2C405&ssl=1
      dexprs dexprs 3 minutes ago
      Bought back FSK 40 Calls for a 40% gain.
      Rolled CLFD further out for a strike price of 45 from 40. It was bought at $69.
      Gmenfan Gmenfan 3 minutes ago
      https://i0.wp.com/politicallyincorrecthumor.com/wp-content/uploads/2024/07/changing-clowns-wont-change-circus-actors-scripted-puppeteers.jpg?resize=583%2C421&ssl=1
      Viking61 Viking61 4 minutes ago
      Still early Sammy!🤞
      FNMA
      LVerstee LVerstee 4 minutes ago
      I hoped the same. But again a deadline (today) is not met. And pushed back further.

      How long will you wait? Another year? And will you post more money while you are at it?
      ITUP
      $Green$ $Green$ 4 minutes ago
      You’re right on that actually, my sources say that Blackrocks Aladdin bot is doing about 80% of the buying in the market recently
      SPY
      powerbattles powerbattles 4 minutes ago
      $SGMO awesome just reloaded .54
      07/24/24 12:56 PM ET Buy 3900 SGMO Executed @ $0.54
      07/24/24 12:56 PM ET Buy 100 SGMO Executed @ $0.54
      07/24/24 12:56 PM ET Buy 200 SGMO Executed @ $0.54
      07/24/24 12:56 PM ET Buy 2150 SGMO Executed @ $0.54
      07/24/24 12:56
      SGMO
      delerious1 delerious1 4 minutes ago
      I wouldn't call them a "scam"...many are genuine companies that are simply trying to survive....look at the last hot sector, Pharma...many companies tried hard to succede but failed when the market died...some moved on trying to find the next Hot sector and the struggle repeats.

      BTW w
      HIRU
      Monksdream Monksdream 5 minutes ago
      It has become a dilution machine
      DJT
      hotdawg hotdawg 5 minutes ago
      EOD 14 would be a good start for the reversal.
      BLEG
      Rum_Tequila Rum_Tequila 5 minutes ago
      Vivos told me Saturday to look at the FDA website, which says automatic approval (silence from FDA) is 30 days from the date application is received, which is July 28

      pop the bubbly Monday July 29
      RDGL
      LVerstee LVerstee 5 minutes ago
      The only reason why I turned more aggressive is because I learned something about the effects that non-payment had on an India employee's family. The total disregard and dismissive response to that situation displayed, that made my blood boil. Zip file.
      ITUP
      Lokotony Lokotony 5 minutes ago
      JUST as I thought the day couldn't get any worse in a HORRIBLE market day.......NSAV double down!
      NSAV
      Margin Buu Margin Buu 6 minutes ago
      Yes, it was a request but you’d have a difficult time explaining why this wouldn’t be considered an unmet medical need, which would fall under the 150 day process.

      The current standard of care has an abysmal 5% survival rate at 5 years, and DCVax more than doubles that to over %13 (5
      NWBO
      Wayne R Wayne R 6 minutes ago
      Maybe it was the chickens that were fully executed 🤣
      SPZI
      jimr1717 jimr1717 6 minutes ago
      Great catch.. Part of that pump program
      IFUS
      Cartmontster Cartmontster 6 minutes ago
      Wow!!! I just noticed the price added a few 0's!!!! Unreal!!! $50 I can get 50M shares!!! What a waste of a company. Kay & Co. are nothing but White Collar scam artists.
      ZRFY

      Your Recent History

      LSE
      JCGI
      Jpmorgan China Growth & ...
      Delayed Upgrade Clock